Lung Cancer
Volume 66, Issue 3 , Pages 365-371 , December 2009

A novel clinical prognostic score incorporating the number of resected lymph-nodes to predict recurrence and survival in non-small-cell lung cancer

  • Emilio Bria

      Affiliations

    • Department of Medical Oncology, Regina Elena National Cancer Institute, Via Elio Chianesi 53, 00144 Rome, Italy
    • Both authors (E.B. & M.M.) equally contributed to this work.
    • Corresponding Author InformationCorresponding author. Tel.: +390652666132; fax: +390652666219.
    • ,
  • Michele Milella

      Affiliations

    • Department of Medical Oncology, Regina Elena National Cancer Institute, Via Elio Chianesi 53, 00144 Rome, Italy
    • Both authors (E.B. & M.M.) equally contributed to this work.
    • ,
  • Isabella Sperduti

      Affiliations

    • Biostatistics, Regina Elena National Cancer Institute, Rome, Italy
    • ,
  • Gabriele Alessandrini

      Affiliations

    • Thoracic Surgery, Regina Elena National Cancer Institute, Rome, Italy
    • ,
  • Paolo Visca

      Affiliations

    • Pathology, Regina Elena National Cancer Institute, Rome, Italy
    • ,
  • Felicita Corzani

      Affiliations

    • Biostatistics, Regina Elena National Cancer Institute, Rome, Italy
    • ,
  • Diana Giannarelli

      Affiliations

    • Biostatistics, Regina Elena National Cancer Institute, Rome, Italy
    • ,
  • Virna Cerasoli

      Affiliations

    • Biostatistics, Regina Elena National Cancer Institute, Rome, Italy
    • ,
  • Federica Cuppone

      Affiliations

    • Department of Medical Oncology, Regina Elena National Cancer Institute, Via Elio Chianesi 53, 00144 Rome, Italy
    • ,
  • Fabiana Letizia Cecere

      Affiliations

    • Department of Medical Oncology, Regina Elena National Cancer Institute, Via Elio Chianesi 53, 00144 Rome, Italy
    • ,
  • Antonio Marchetti

      Affiliations

    • Clinical Research Center, Center of Excellence on Aging, University-Foundation, Chieti, Italy
    • ,
  • Rocco Sacco

      Affiliations

    • Department of Surgery, University of Chieti, Italy
    • ,
  • Felice Mucilli

      Affiliations

    • Department of Surgery, University of Chieti, Italy
    • ,
  • Sara Malatesta

      Affiliations

    • Clinical Research Center, Center of Excellence on Aging, University-Foundation, Chieti, Italy
    • ,
  • Luigi Guetti

      Affiliations

    • Department of Surgery, University of Chieti, Italy
    • ,
  • Luca Vitale

      Affiliations

    • Department of Surgery, University of Chieti, Italy
    • ,
  • Anna Ceribelli

      Affiliations

    • Department of Medical Oncology, Regina Elena National Cancer Institute, Via Elio Chianesi 53, 00144 Rome, Italy
    • ,
  • Massimo Rinaldi

      Affiliations

    • Department of Medical Oncology, Regina Elena National Cancer Institute, Via Elio Chianesi 53, 00144 Rome, Italy
    • ,
  • Edmondo Terzoli

      Affiliations

    • Department of Medical Oncology, Regina Elena National Cancer Institute, Via Elio Chianesi 53, 00144 Rome, Italy
    • ,
  • Francesco Cognetti

      Affiliations

    • Department of Medical Oncology, Regina Elena National Cancer Institute, Via Elio Chianesi 53, 00144 Rome, Italy
    • ,
  • Francesco Facciolo

      Affiliations

    • Thoracic Surgery, Regina Elena National Cancer Institute, Rome, Italy

Received 28 December 2008 ,Revised 5 February 2009 ,Accepted 25 February 2009.

References 

  1. Gralow J, Ozols RF, Bajorin DF, et al. Clinical cancer advances 2007: major research advances in cancer treatment, prevention, and screening—a report from the American Society of Clinical Oncology. J Clin Oncol. 2008;26:313–325
  2. Jemal A, Siegel R, Ward E, et al. Cancer statistics 2007. CA Cancer J Clin. 2007;57:43–66
  3. Spira A, Ettinger DS. Multidisciplinary management of lung cancer. N Engl J Med. 2004;350:379–392
  4. Rusch VW, Crowley J, Giroux DJ, et al. The IASLC Lung Cancer Staging Project: proposals for the revision of the N descriptors in the forthcoming seventh edition of the TNM classification for lung cancer. J Thorac Oncol. 2007;2:603–612
  5. Gajra A, Newman N, Gamble GP, et al. Effect of number of lymph nodes sampled on outcome in patients with stage I non-small-cell lung cancer. J Clin Oncol. 2003;21:1029–1034
  6. Scott WJ, Howington J, Feigenberg S, et al. Treatment of non-small cell lung cancer stage I and stage II: ACCP evidence-based clinical practice guidelines (2nd edition). Chest. 2007;132:234S–242S
  7. Luzzi L, Paladini P, Ghiribelli C, et al. Assessing the prognostic value of the extent of mediastinal lymph node infiltration in surgically-treated non-small cell lung cancer (NSCLC). Lung Cancer. 2000;30:99–105
  8. McNeil C. New NSCLC staging raises treatment issues. J Natl Cancer Inst. 2007;99:1748–1749
  9. Arriagada R, Bergman B, Dunant A, et al. Cisplatin-based adjuvant chemotherapy in patients with completely resected non-small-cell lung cancer. N Engl J Med. 2004;350:351–360
  10. Douillard JY, Rosell R, De Lena M, et al. Adjuvant vinorelbine plus cisplatin versus observation in patients with completely resected stage IB–IIIA non-small-cell lung cancer (Adjuvant Navelbine International Trialist Association [ANITA]): a randomised controlled trial. Lancet Oncol. 2006;7:719–727
  11. Winton T, Livingston R, Johnson D, et al. Vinorelbine plus cisplatin vs. observation in resected non-small-cell lung cancer. N Engl J Med. 2005;352:2589–2597
  12. Johnson PM, Porter GA, Ricciardi R, Baxter NN. Increasing negative lymph node count is independently associated with improved long-term survival in stage IIIB and IIIC colon cancer. J Clin Oncol. 2006;24:3570–3575
  13. Karlsson P, Cole BF, Price KN, et al. The role of the number of uninvolved lymph nodes in predicting locoregional recurrence in breast cancer. J Clin Oncol. 2007;25:2019–2026
  14. Kassouf W, Agarwal PK, Herr HW, et al. Lymph node density is superior to TNM nodal status in predicting disease-specific survival after radical cystectomy for bladder cancer: analysis of pooled data from MDACC and MSKCC. J Clin Oncol. 2008;26:121–126
  15. Iasonos A, Schrag D, Raj GV, Panageas KS. How to build and interpret a nomogram for cancer prognosis. J Clin Oncol. 2008;26:1364–1370
  16. Cahan WG, Watson WL, Pool JL. Radical pneumonectomy. J Thorac Surg. 1951;22:449–473
  17. Martini N, Flehinger BJ. The role of surgery in N2 lung cancer. Surg Clin North Am. 1987;67:1037–1049
  18. Naruke T. Mediastinal lymph node dissection. In: Shields TW, editor. General thoracic surgery, 5th ed. Philadelphia: Lippincott Williams and Wilkins 2000. p. 1343–56.
  19. Shuster JJ. Median follow-up in clinical trials. J Clin Oncol. 1991;9:191–192
  20. Cox DR. Regression models and life tables. J Royal Stat Soc. 1972;4:187–200
  21. Hess KR. Graphical methods for assessing violations of the proportional hazards assumption in Cox regression. Stat Med. 1995;14:1707–1723
  22. Kaplan EL, Meier P. Non parametric estimation from incomplete observations. J Am Stat Assoc. 1958;53:457–481
  23. Sauerbrei W, Schumacher M. A bootstrap resampling procedure for model building: application to the Cox regression model. Stat Med. 1992;11:2093–2109
  24. Efficace F, Bottomley A, Smit EF, et al. Is a patient's self-reported health-related quality of life a prognostic factor for survival in non-small-cell lung cancer patients? A multivariate analysis of prognostic factors of EORTC study 08975. Ann Oncol. 2006;17:1698–1704
  25. Network NCC. NCCN Clinical Practice Guidelines in Oncology – Non-Small-Cell Lung Cancer. V.2.2008. In Edition 2008.
  26. Asamura H, Goya T, Koshiishi Y, et al. A Japanese Lung Cancer Registry study: prognosis of 13 010 resected lung cancers. J Thorac Oncol. 2008;3:46–52
  27. Ingle AM, Kumar P, Griggs MM, et al. Impact of number of lymph nodes (LN) examined at the time of surgical resection (Sx) on the survival of stage IA non-small cell lung cancer (NSCLC) patients (pts). J Clin Oncol (Meeting Abstracts). 2008;26:7534
  28. Goldstraw P, Crowley J, Chansky K, et al. The IASLC Lung Cancer Staging Project: proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM Classification of malignant tumours. J Thorac Oncol. 2007;2:706–714
  29. Pignon JP, Tribodet H, Scagliotti GV, et al. Lung adjuvant cisplatin evaluation: a pooled analysis by the LACE Collaborative Group. J Clin Oncol. 2008;26:3552–3559
  30. Le Chevalier T, Dunant A, Arriagada R et al. Long-term results of the International Adjuvant Lung Cancer Trial (IALT) evaluating adjuvant cisplatin-based chemotherapy in resected non-small cell lung cancer (NSCLC). J Clin Oncol (Meeting Abstracts) 2008;26:7507.
  31. Chen HY, Yu SL, Chen CH, et al. A five-gene signature and clinical outcome in non-small-cell lung cancer. N Engl J Med. 2007;356:11–20
  32. Lau SK, Boutros PC, Pintilie M, et al. Three-gene prognostic classifier for early-stage non small-cell lung cancer. J Clin Oncol. 2007;25:5562–5569
  33. Bianchi F, Nuciforo P, Vecchi M, et al. Survival prediction of stage I lung adenocarcinomas by expression of 10 genes. J Clin Invest. 2007;117:3436–3444

☆ Presented as preliminary data at the 44th American Society of Clinical Oncology meeting held in Chicago, IL, May 30th–June 3rd, 2008.

PII: S0169-5002(09)00122-6

doi: 10.1016/j.lungcan.2009.02.024

Lung Cancer
Volume 66, Issue 3 , Pages 365-371 , December 2009

Article Tools

* Image Usage & Resolution